Detalhe da pesquisa
1.
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo.
J Antimicrob Chemother
; 78(4): 946-952, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36760083
2.
Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
Drug Metab Dispos
; 46(11): 1497-1506, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30135242
3.
Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2.
Antiviral Res
; 224: 105852, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428748
4.
In Vivo Antiviral Activity of Baloxavir against PA/I38T-Substituted Influenza A Viruses at Clinically Relevant Doses.
Viruses
; 15(5)2023 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243240
5.
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters.
Sci Transl Med
; 15(679): eabq4064, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327352
6.
Generation of Human-Induced Pluripotent Stem Cell-Derived Functional Enterocyte-Like Cells for Pharmacokinetic Studies.
Stem Cell Reports
; 16(2): 295-308, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33513361
7.
Generation of intestinal organoids derived from human pluripotent stem cells for drug testing.
Sci Rep
; 10(1): 5989, 2020 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32249832
8.
The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro-in vivo correlation of nanocrystals.
Eur J Pharm Biopharm
; 146: 84-92, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31816392
9.
The first total synthesis of nidulalin A, a dihydroxanthone possessing multiple bioactivities.
J Antibiot (Tokyo)
; 62(8): 469-70, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19575043